Federica Genovese

Head of department

Norwich BioScience Institutes
Country flagDenmark

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Federica Genovese is the Head of Department at Nordic Bioscience in Denmark. Her research focuses on cardiovascular outcomes, extracellular matrix-associated diagnostics, and renal disease progression. She has contributed to several recent articles exploring biomarkers related to cardiovascular and chronic diseases, including the associations of collagen type III and Endotrophin with patient outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Kidney fibrosis is the hallmark of chronic kidney disease (CKD) and is characterized by an imbalanced extracellular matrix (ECM) remodeling. Collagen type III is one of the main ECM components of the interstitial matrix of the kidney. We hypothesized that measuring three biomarkers of collagen type III reflecting different aspects of this protein turnover (C3M, C3C, and PRO-C3) may provide different information about the fibrotic burden in patients with IgA nephropathy (IgAN). We examined a cohort of 134 patients with IgAN. The three collagen type III biomarkers were measured in serum (S) and in urine (U) samples taken on the same day before kidney biopsy was performed. Biopsies were evaluated for interstitial fibrosis and tubular atrophy, according to the Banff and MEST-C scores. S-PRO-C3 and S-C3C correlated with the degree of fibrosis in the biopsy, whereas U-C3M/Cr had an inverse correlation with fibrosis. U-C3M/Cr had the highest discrimination ability for advanced fibrosis, which was maintained after adjustment for the other collagen type III biomarkers, proteinuria, and serum creatinine. The data presented in this study indicate that measuring the different fragments of the same ECM protein and in different matrices provides a variety of information regarding pathological kidney tissue alterations in patients with IgAN.

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Elisabeth Bendstrup

Aarhus University

DENMARK
View details

Scott Friedman

Dean for Therapeutic Discovery

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Paresh Thakker

Global Head, Translational Biomarkers Research

Takeda Pharmaceutical Company

UNITED STATES
View details

Andrea Heinz

Københavns Universitet

DENMARK
View details

Vladimir Tesar

-

CZECH REPUBLIC
View details

Ali Mobasheri

Professor of Musculoskeletal Biology

University of Oulu

FINLAND
View details

Johann Bauersachs

Head

Medizinische Hochschule Hannover

GERMANY
View details

Marie Vestergaard Lukassen

Technical University of Denmark

DENMARK
View details

Ole Hilberg

-

DENMARK
View details

Alexander Eckersley

The University of Manchester

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.